Cargando…
Galactosylceramidase deficiency and pathological abnormalities in cerebral white matter of Krabbe disease
Krabbe Disease (KD) is an autosomal recessive disorder that results from loss-of-function mutations in the GALC gene, which encodes lysosomal enzyme galactosylceramidase (GALC). Functional deficiency of GALC is toxic to myelin-producing cells, which leads to progressive demyelination in both the cen...
Autores principales: | Iacono, Diego, Koga, Shunsuke, Peng, Hui, Manavalan, Arulmani, Daiker, Jessica, Castanedes-Casey, Monica, Martin, Nicholas B., Herdt, Aimee R., Gelb, Michael H., Dickson, Dennis W., Lee, Chris W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10474820/ https://www.ncbi.nlm.nih.gov/pubmed/36113749 http://dx.doi.org/10.1016/j.nbd.2022.105862 |
Ejemplares similares
-
Neuron-specific ablation of the Krabbe disease gene galactosylceramidase in mice results in neurodegeneration
por: Kreher, Conlan, et al.
Publicado: (2022) -
Brainstem development requires galactosylceramidase and is critical for pathogenesis in a model of Krabbe disease
por: Weinstock, Nadav I., et al.
Publicado: (2020) -
β-Galactosylceramidase Deficiency Causes Bone Marrow Vascular Defects in an Animal Model of Krabbe Disease
por: Belleri, Mirella, et al.
Publicado: (2019) -
β-Galactosylceramidase Deficiency Causes Upregulation of Long Pentraxin-3 in the Central Nervous System of Krabbe Patients and Twitcher Mice
por: Coltrini, Daniela, et al.
Publicado: (2022) -
Brain Targeted AAV1-GALC Gene Therapy Reduces Psychosine and Extends Lifespan in a Mouse Model of Krabbe Disease
por: Herdt, Aimee R., et al.
Publicado: (2023)